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Spontaneous splanchnic dissection: Application
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Thomas J. Takach, MD, Jeko M. Madjarov, MD, Jeremiah H. Holleman, MD, Francis Robicsek, MD,
and Timothy S. Roush, MD, Charlotte, NC
Background: Spontaneous splanchnic dissection (SSD) occurs infrequently and has a poorly defined natural history. Few
studies address the application, timing, and consequences of therapeutic options. Our goal was to apply conservative
(non-operative) management in the care of each patient, reserving interventions for specific indications that may be
predictive of adverse outcomes.
Methods: Between 2003 and 2008, 10 consecutive patients (mean age 54.7-years-old, 70.0% male) presented with 11 SSDs
involving either the celiac artery (n  6), superior mesenteric artery (n  3), or both (n  1). Each patient had acute,
spontaneous onset of persistent abdominal pain and was diagnosed with SSD following multidetector row computed
tomographic angiography (CTA). Non-operative management (anticoagulation, anti-impulse therapy, analgesics, and serial
CTA examinations) was initially used in 9 patients. Endovascular (n  2) or operative (n  2) intervention was performed
either immediately (n 1) or following failed medical management (n 3) in 4 patients for specific indications that included
persistent symptoms (n  3), expansion of false lumen (n  3), and/or radiologic malperfusion (n  3).
Results: All patients were asymptomatic after successful non-operative management or following intervention. No
morbidity occurred. Upon complete follow-up (mean 13.4 months, range, 2 to 36 months), all patients remained
asymptomatic. Preservation of distal perfusion with either thrombosis or ongoing regression of false lumen was achieved
in 5 patients who received only non-operative management and in 4 patients following intervention. A stable chronic
dissection was present in 1 patient who had only non-operative management.
Conclusion: Successful outcomes following SSD may be achieved with either non-operative therapy alone or intervention if
persistent symptoms, expansion of false lumen, and/or malperfusion occur. The unpredictable response of the false lumen to
conservative management mandates close, long-term follow-up. Endovascular and operative interventions produced similar
outcomes in a small number of patients with limited follow-up. Although SSD is currently perceived as rare, the increasing use
of CTA may prove that the true incidence has been underestimated. (J Vasc Surg 2009;50:557-63.)Spontaneous splanchnic dissection (SSD) is uncom-
mon and few studies address the application, timing, and
consequences of therapeutic options. The natural history of
this problem is ill defined. Selective cases have been known
to undergo spontaneous resolution with thrombosis of
false lumen and preservation of distal flow. However, other
cases have been associated with both significant morbidity
and mortality. In this small study, our goal was to apply
conservative (non-operative) management in the care of
each patient, reserving the use of interventions for specific
indications that may be predictive of adverse outcomes.
METHODS
Between 2003 and 2008, 10 consecutive patients
(mean age 54.7 years, 70.0% male) presented to our insti-
tution with 11 SSDs involving either the celiac artery (n 
6), superior mesenteric artery (n 3), or both (n 1). The
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Vascular Surgery.doi:10.1016/j.jvs.2009.02.244demographic data and risk factors for these patients are
summarized in Table I. Although 4 patients had a history of
well-controlled hypertension, all patients were normoten-
sive upon initial evaluation. Each patient had acute sponta-
neous onset of persistent abdominal pain and was diag-
nosed with SSD following multidetector row computed
tomographic angiography (CTA). Each initial CTA exam-
ination was performed within 24 hours following onset of
symptoms. No patient had concomitant aortic disease,
including dissection, aneurysm, or significant atherosclero-
sis. One patient had significant atherosclerosis involving the
major, concomitant (non-dissected) mesenteric vessel.
On the basis of anatomic findings at initial diagnostic
imaging, each patient received either immediate intervention
or non-operative therapy (anticoagulation, anti-impulse ther-
apy, analgesics, and serial CTA examinations) (Table II).
The primary anatomic determinant regarding decision-
making at this point was the presence or absence of malp-
erfusion. Malperfusion was defined as greater than 80%
compromise of the true lumen, comparing the smallest true
lumen diameter with a reference diameter of contiguous,
parallel, non-dissected vessel. Malperfusion syndrome was
defined as themorbid consequences of either diminished or
absent flow due to dissection.
In the absence of malperfusion, non-operative (conserva-
tive)management was initially used in 9 patients. The patients
receiving conservative management were discharged follow-
ing initial diagnosis upon resolution of symptoms. Staged
557
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at 30 days, then every 3 months until complete regression
(thrombosis) of false lumen. Anticoagulation was continued
empirically until follow-up CTA examination demonstrated
either regression or unchanged diameter of false lumen. Anti-
impulse therapy included continuation of antihypertensive
therapy in those patients previously receiving suchmedication
and the addition of beta-blockade therapy until CTA docu-
Table I. Patient demographics, risk factors, and managem
Patients 10 (100
Mean age (range) 54.7 years (42
Gender
Male 7 (70.
Female 3 (30.
Hypertension 4 (40.
Tobacco use 4 (40,
Diabetes mellitus 0 (0)
Coronary artery disease 3 (30.
Peripheral vascular occlusive disease 1 (10.
Dyslipidemia 2 (20.
Chronic obstructive pulmonary disease 1 (10.
Table II. Dissection characteristics and outcomesa
Dissections 11 (100%)
Vessel of origin
Celiac artery 7 (63.6%)
Superior mesenteric artery 4 (36.4%)
Extent
Localized 4 (36.4%)
Diffuse 7 (63.6%)
Branch vessel involvement
Present 8 (72.7%)
Absent 3 (27.3%)
False lumen natural history*
Regression or thrombosis* 6 (60.0%)
Expansion* 3 (30.0%)
No change* 1 (10.0%)
Mean follow-up (range)
(10 patients) 13.4 months (2-36 months)
Outcome (by patienta)
Spontaneous regression 5 (50.0%)
Chronic dissection 1 (10.0%)
Intervention 4 (40.0%)
Type
Endovascular stent 2 (20.0%)
Laparotomy 1 (10.0%)
Laparotomy/bypass 1 (10.0%)
Timing
Immediate 1 (10.0%)
Delayed 3 (30.0%)
Mean time (range) 20 days (2-30 days)
Indication
Persistent symptoms 3 (30.0%)
False lumen expansion 3 (30.0%)
Malperfusion 3 (30.0%)
*Excludes dissection in patient treated with immediate intervention.
aIncludes 11 dissections in 10 patients.mentation of false lumen thrombosis.The initial CTA finding of malperfusion or follow-up
CTA findings of delayed-onset malperfusion, distal propa-
gation of dissection, or expansion of false lumen were
specific indications for intervention. The presence of per-
sistent, worsening, or recurrent pain at any time following
initial diagnosis prompted a full investigation including
repeat CTA examination in order to determine cause.
In patients requiring intervention, less invasive endovas-
cular techniques were used preferentially. Open operative
procedures were used when assessment of bowel viability was
mandated by the individual case. Following endovascular in-
tervention, patients were discharged on dual (aspirin and
clopidogrel) anti-platelet therapy after radiologic imaging
confirmed elimination of false lumen flow, unimpeded true
lumen flow, and patency of branch vessels.
RESULTS
Dissection characteristics and outcomes are summa-
rized in Table II. The dissections were characterized by
anatomic variability (vessel of origin, localized vs diffuse
extent, presence or absence of branch vessel involvement)
and an unpredictable response of the false lumen (expan-
sion vs regression [thrombosis] vs no change, rate of
change) to conservative management. Successful responses
to conservative management occurred in both localized
(Fig 1) and diffuse (Fig 2) disease either with (Fig 2) or
without (Fig 1) branch vessel involvement. The false lu-
men(s) in those patients, in general, would gradually re-
gress in size over (several months) time until complete
obliteration of the false lumen with unimpeded distal pa-
tency was achieved (Fig 1, c). This group also included 2
patients with recently diagnosed SSD and limited follow-up
(mean 2.0 months). These 2 patients remained asymptom-
atic and had ongoing regression of false lumen size but had
not yet achieved complete obliteration of the false lumen
while receiving conservative management.
Endovascular stent placement (n  2) or laparotomy/
mesenteric bypass (n  2) was performed either at initial
diagnostic imaging (n  1) or following failed medical
Management
Intervention
(open/endovascular)
Conservative
(non-operative)
4 (40.0%) 6 (60.0%)
ears)
4 (40.0%) 3 (30.0%)
0 3 (30.0%)
2 (20.0%) 2 (20.0%)
2 (20.0%) 2 (20.0%)
0 0
1 (10.0%) 2 (20.0%)
1 (10.0%) 0
1 (10.0%) 1 (10.0%)
0 1 (10.0%)ent
%)
-75 y
0%)
0%)
0%)
0%)
0%)
0%)
0%)management (n  3) in 4 patients for specific indications
in size of false lumen.
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false lumen (n  3), and/or radiologic malperfusion (n 
3). In this study, our patients with a radiologic diagnosis of
malperfusion had near-occlusion of true lumen flow, ex-
ceeding our diagnostic criteria of 80% compromise of true
lumen flow in each case. Failure of conservative manage-
ment occurred in 3 patients who required intervention.
The first patient had worsening pain at 2 days and distal
propagation of dissection, occurring in two separate mes-
enteric vessels. The second patient had recurrent pain at 30
days with CTA documentation of both false lumen expan-
sion and malperfusion. The third patient remained normo-
tensive and asymptomatic following hospital discharge.
However, routine follow-up CTA at 30 days demonstrated
the presence of malperfusion (Fig 3, a, b) and expansion of
false lumen (Fig 3, b, c). The patient was treated with
endovascular stent placement (Fig 3, d).
In the 2 remaining patients, 1 had malperfusion (near
occlusion of true lumen) (Fig 4) at time of initial diagnosis,
requiring immediate intervention (endovascular stent
placement) and the other had a complex distal perfusion
pattern in which major branch vessel perfusion originated
from both the true and false lumens (Fig 5). In that patient
with a superiormesenteric artery (SMA) dissection, the true
lumen supplied one proximal colic branch and the false
lumen supplied a replaced right hepatic artery and all remain-
ing colic branches. The false lumen in this patient has re-
mained patent and unchanged in size at 36-month follow-up
and is considered a stable, chronic dissection.
Open operative procedures were used in 1 patient with
concomitant celiac artery dissection and SMA stenosis that
required concomitant revascularization, and in 1 patient with
concomitant celiac and SMA dissections. The remaining 2
patients who required intervention were treated with endo-
vascular stent placement using either self-expanding (Wall-
stent; Boston Scientific, Natick, Mass) or balloon-expandable
Fig 2. Computed tomographic scan three-dimensional (3D) recon-
struction of a 55-year-old female with a diffuse celiac artery dissection
extending to and involving the origins of all major branch vessels.Fig 1. Computed tomographic scan cross-section (a) and three-
dimensional (3D) reconstruction (b and c) views of a 43-year-old
female treated with conservative management only demonstrating
(a) classic “double-lumen” sign (arrow) on initial study, (b) local-
ized celiac artery dissection at time of initial diagnosis, and (c)
complete resolution of dissection with thrombosis of false lumen
and unimpeded distal flow at 9-month follow-up. Interval staged
examinations (not depicted) had demonstrated gradual reduction(Genesis; Cordis Corp, Warren, NJ) bare metal devices.
astric,
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operative management or following intervention. No mor-
bidity occurred. Upon complete follow-up (mean 13.4
months, range, 2 to 36 months), all patients remained
asymptomatic. Preservation of distal perfusion with either
thrombosis or ongoing regression of false lumen was
achieved in 5 patients treated with only non-operative
management and in 4 patients following intervention. In
those patients, limited follow-up (mean 2.0 months) in two
recent cases treated with conservative management only
accounted for the finding of ongoing regression without
thrombosis. In contrast, extended follow-up in the remain-
ing patients demonstrated either immediate thrombosis of
false lumen after intervention or delayed thrombosis after
several months in patients receiving conservative manage-
ment only. Endovascular and operative interventions pro-
duced similar outcomes in a small number of patients with
limited follow-up. A stable, chronic dissection was present
Fig 3. Computed tomographic scan cross-section (a) and t
namically stable, asymptomatic 53-year-old male with a celiac
follow-updemonstrating (a)malperfusion (nearocclusionof tr
vs 9.0 5.0mmat initial diagnosis), notemechanical compre
pre-intervention anatomy notable for false lumen/dissection o
vessels; and (d) completion study following endovascular stent
lumen and unimpeded patency of major branch vessels (left gin 1 patient who had only non-operative management.DISCUSSION
Over the last 3 decades, the development and applica-
tion of diagnostic methods, the evolving clarification of
natural history, and the development and application of
therapeutic techniques for spontaneous splanchnic dissec-
tions have been directly influenced by technological ad-
vances. Prior to 1975, all known cases of SSD were re-
ported following either general necropsy series or the
demise of the individual patient.1,2 Although angiography
alone was used to diagnose several initial cases after 1975,
the development and use of first generation computed
tomography scanners proved to be a more effective screen-
ing tool than any other existing technique in patients with
this problem.3-6 In contrast to a 100% mortality rate in 11
reported cases before 1975, only two deaths have been
reported since that time.2,7,8 Between 1975 and 2008, 31
cases of spontaneous celiac artery dissection and 74 cases of
imensional (3D) reconstructions (b, c, and d) of a hemody-
dissection undergoing conservative management at 30 days
en), seearrow; (a,b) false lumenexpansion (16.39.4mm
of true lumen by the expanded false lumen, see arrow; (c) key
at distal celiac artery with uninvolved origins of major branch
ment confirming complete regressionwith thrombosis of false
splenic, and common hepatic arteries).hree-d
artery
ue lum
ssion
rigin
placespontaneous SMA dissection have been reported.2,8-14 The
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believed to reflect a changing pattern but rather the lack of
an effective diagnostic screening method prior to 1975 and
the hesitancy of investigators to report adverse outcomes or
bad results in the small number of patients with this problem
since 1975.15 Although mortality has been less frequently
documented, SSD has been reported to have caused sple-
nic infarction,16,17 obstructive jaundice,18 bowel infarc-
tion,7,19-22 and diffuse obliteration of small mesenteric ves-
sels that required bowel transplantation.2
Although the 11 SSDs in this report may reflect an
unusual clustering of infrequent events, the introduction of
multi-slice CTA and its aggressive use in patients with
abdominal pain of uncertain origin may account for the
number of cases, suggesting that the true incidence of this
problem has been underestimated. This hypothesis is fur-
ther supported by a recent series from Japan with 19
patients that used similar diagnostic screening protocols.11
Treatment regimens have also evolved over time, having
Fig 4. Computed tomographic scan sagittal view (a) and three-dimen-
sional (3D) reconstruction (b) of superiormesenteric artery dissection in
a 49-year-oldmale demonstrating distalmalperfusion due tomechanical
compression of true lumen by false lumen (see arrows) at time of initial
diagnosis that required placement of endovascular stent.been influenced separately by an increased understanding ofthe natural history of the problemand advances in technology.
Initial cases were treated successfully with open resection and
either bypass or transposition of the distal artery.3,4 In 1994,
Ambo et al23 reported the successful, non-operative (conser-
vative) management of an SMA dissection with subsequent
thrombosis of the false lumen and preservation of distal flow.
However, this approach has not proven to be universally
successful. Following the initial success of Ambo and associ-
ates, 10 consecutive patients with SSD in separate case reports
over a span of 7 years were initially treated with non-operative
therapy.24-31Of those patients, 3 (30.0%) required late (mean
6.7 months) conversion to an open or endovascular interven-
tion.28-30Over that same time period, an additional 5 patients
in separate case reports were treated immediately with either
an open or endovascular intervention.32-36 Endovascular
stent placementwas introduced as follow-up therapy for failed
medical management in 200028 and as primary therapy in
2004.15 Short-term follow-up has not documented any mor-
bidity. However, the use of endovascular stents for treatment
of iatrogenic splanchnic dissections has been associated with
infrequent vessel restenosis.37,38
Despite a limited number of patients in this study, vari-
abilitywas foundwith respect to extent of dissection (localized
vs diffuse), involvement of branch vessels, false lumen natural
history (expansion vs regression vs no change), and rate of
change. Furthermore, absence of either clinical symptoms or
hemodynamic instability did not preclude the delayed occur-
rence of either radiologic malperfusion or false lumen expan-
sion. The small number of patients in this study precluded an
effective identification of prognostic risk factors. The general
absence of concomitant aortic disease, mesenteric atheroscle-
rosis, and a history of connective tissue disorders in such
patients in both this and other reports have led others to
suggest alternative etiologic factors including segmental arte-
Fig 5. Computed tomographic scan sagittal view of superior mes-
enteric artery dissection in a 54-year-old male with the true lumen
providing perfusion of first major colic branch and false lumen pro-
viding perfusion of a replaced right hepatic artery and all remaining
colic branches. The false lumen remained patent and unchanged in
size on follow-up, constituting a stable, chronic dissection.rialmediolysis, adventitial inflammation, and disruption of the
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tion process as described here and in other reports may repre-
sent part of a pathologic continuum that also includes pene-
trating ulcer, pseudoaneurysm, and aneurysm.40 While
etiology and natural history remain poorly-defined in these
patients, the radiologic findings of “double-lumen” sign on
sagittal (Figs 4, a and 5, a) and cross-section (Fig 1, a) CTA
views; false lumen expansion and subsequent compression of
true lumenflow in the absence of extrinsic compression due to
contiguous, extravascular tissue (Fig 3, a, b, c, and Fig 4);
narrow false lumen orifice; and the ability to effectively treat
this problem with bare-metal stents (Fig 3, d and Fig 4, a)
have separated this problem from other vascular pathology.
A major concern regarding management of these pa-
tients is identification of a “trigger” that would initiate
either operative or endovascular intervention in order to
preclude adverse sequelae. Our management decisions
were guided by two major influences, natural history be-
havior in a limited number of previously reported patients
with the problem, and physiologic principles derived from
surgical management of dissections in other locations.
Non-operative (conservative) therapy is warranted in
hemodynamically stable patients with either acute SSD
without anatomic malperfusion or chronic SSD without
recurrent symptoms, expanding false lumen, or malperfu-
sion. This is justified on the basis of known spontaneous
regression of certain SSDs,23 the infrequent occurrence
(one reported case) of rupture,8 and the documented ten-
dency of chronic descending aorta and descending aortic
branch dissections to demonstrate slow rather than abrupt or
rapid change, permitting effective serial imaging in follow-
up.41,42 In contrast, immediate operative or endovascular
intervention is warranted if any of the previously docu-
mented adverse sequelae of SSD are believed to be immi-
nent. Anatomic (vascular) malperfusion may generate
thromboemboli or produce direct end-organ ischemia, re-
sulting in a morbid outcome.16,17,19-22 Persistent symp-
toms, primarily pain, may be indicative of either undetected
propagation of dissection, expansion of false lumen, or
ischemia.42,43 Froment et al15 reported that patients with
symptomatic lesions at presentation are more likely to fail
conservative management, having identified a 50% failure
rate in patients with such lesions. Expansion of false lumen
may cause either rupture or, as demonstrated in this study,
malperfusion secondary to mechanical compression of true
lumen flow (Fig 3, a, b).8 Svensson et al41 reviewed dissec-
tion physiology and reported that “growth begets faster
growth,” suggesting that any growth will exponentially
increase over time and mandating close follow-up if imme-
diate intervention is not undertaken. The inability to predict
either regression or expansion for any specific SSD false lu-
men, the onset of latemalperfusion and false lumen expansion
in the absence of either symptoms or hemodynamic instability
in this study, and literature documentation of several cases
requiring late conversion of non-operative management to
direct interventionmandates life-long serial imaging as part of
follow-up in patients with a chronic dissection.6,29,30,44,45This study summarizes our framework and justification
for management of patients with such problems. In this small
study, we experienced a conservative management failure rate
of 33% and a chronic dissection rate of 10%. Our conservative
management failure rate was similar to the 38.5% overall
failure rate in 13 patients analyzed by Froment et al15 in a
comprehensive literature review of management outcomes in
patients with spontaneous SMA dissections. In contrast to
those findings, Takayama et al11 in a recent study reported
that only 1 (5.2%) of their 19 patients required either
operative or endovascular intervention. Furthermore, 13
(68.4%) of their patients had patent and unchanged size of
the dissection false lumens on follow-up imaging, consti-
tuting chronic dissections. The presence of such dissections
are of special concern and necessitate close follow-up, hav-
ing been associated with the late conversion of non-opera-
tive management to either operative or endovascular inter-
vention in several cases.6,29,30,44,45 Studies of dissections at
other locations have reported that a patent false lumen
increases the risk of an adverse outcome.46-48 Although all
patients in this study were symptomatic at presentation,
63.2% of the 19 patients studied by Takayama et al11 were
asymptomatic and found incidentally after radiologic eval-
uation for other reasons. This may account for the larger
number of chronic dissections and fewer patients requiring
intervention in that study.
We conclude that successful outcomes following SSD
may be achieved with either non-operative therapy alone or
intervention if persistent symptoms, expansion of false lumen,
and/or radiologic malperfusion occur. Dissection is a dy-
namic and unpredictable process. In the absence of hyperten-
sion, changemay occur less rapidly in this location than in the
proximal aorta. However, the unpredictable response of the
false lumen to conservative management mandates close, life-
long follow-up. In this study, endovascular and operative
interventions had similar outcomes in a small number of
patients with limited follow-up. The specific application of
either interventional technique should be tailored to the needs
of the individual patient since each technique offers different
advantages and disadvantages. Although SSD is currently
perceived as rare, the increasing use of CTA may prove that
the true incidence of SSD has been underestimated.
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